EGFR and breast cancer: The most frequently observed mutations occurred within the coding region of PIK3CA (6 out of 18 mutations detected) for breast cancer (Fig. 3b) and EGFR (40 out of 57 mutations detected) for NSCLC specimens (Fig. 3c).